06.01.2014 • News

Carlyle Said Close to Buying J&J Diagnostics Unit

Private equity investor Carlyle is in exclusive talks to buy Johnson & Johnson's ortho clinical diagnostics unit for around $4 billion, after knocking Blackstone out of the race, financial market reports said shortly before Christmas. A deal was expected to be concluded in the first half of January.

The unit, described as a small player in a market dominated by larger companies such as Roche, Siemens, Abbott and Danaher, manufactures blood-screening equipment and laboratory blood tests as well as tests capable of identifying blood types and screening for viruses such as HIV and hepatitis C.

At the beginning of 2013, Johnson & Johnson had said it was exploring strategic alternatives for business, a process that could take 12-24 months. Blackstone was reportedly bidding in cooperation with Danaher.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

From Lab to Market Challenge

Vote Now: Germany's Most Promising Chemistry Start-ups
Choose your favourite among the finalists

Vote Now: Germany's Most Promising Chemistry Start-ups

The "From Lab to Market Challenge" brings together the most promising founders from chemistry, materials science, and industrial biotechnology. Starting June 1st, you can cast your public vote for the finalists on CHEManager.com — before the award ceremony with €10,000 in prizes takes place on June 25th.

Top-Feature

most read